- By insider
Chairman, President & CEO of Idexx Laboratories Inc (IDXX) Jonathan W Ayers sold 60,000 shares of IDXX on 08/04/2016 at an average price of $107.69 a share. The total sale was $6.5 million.
IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for the veterinary, bioresearch, water, livestock, poultry and dairy markets. Idexx Laboratories Inc has a market cap of $8.4 billion; its shares were traded at around $107.98 with a P/E ratio of 48.86 and P/S ratio of 5.88. Idexx Laboratories Inc had an annual average EBITDA growth of 13.50% over the past 10 years. GuruFocus rated Idexx Laboratories Inc the business predictability rank of 5-star.
-
Warning! GuruFocus has detected 4 Warning Signs with AMZN. Click here to check it out.
-
The intrinsic value of IDXX
CEO Recent Trades:
-
Chairman, President & CEO Jonathan W Ayers sold 60,000 shares of IDXX stock on 08/04/2016 at the average price of $107.69. The price of the stock has increased by 0.27% since.
For the complete insider trading history of IDXX, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 4 Warning Signs with AMZN. Click here to check it out.
-
The intrinsic value of IDXX